Current Opinion in Rheumatology

ISSN 1040-8711 · Lippincott Williams & Wilkins · United States · active 1989–2026

Metrics

Scimago quartile (2025)
Q1
Cites per paper (2y)
3.9
SJR
1.572
h-index
155

“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric (how the two differ). Citation rates differ enormously between fields, so compare within a discipline. What the other figures mean: journal quartile, SJR, h-index and article processing charge.

Data as of 25 October 2026 (venue index build).

Scimago Journal Rank 2025

In the Scimago Journal Rank 2025 edition, Current Opinion in Rheumatology is Q1 in Rheumatology (#12 of 78 journals).

Scimago 2025 quartile and rank of Current Opinion in Rheumatology in each subject category
Subject categoryQuartileRank in category
RheumatologyQ1#12 of 78
Cites per document (2 years, Scopus)
5.25
Documents indexed in 2025 (Scopus)
66

The quartile is the one Scimago prints for each category. Rank is the journal's position by SJR among the journals Scimago lists in that category (#1 is the highest); “—” means we hold no rank consistent with that quartile. The document count is what Scopus indexed that year, which can be lower than a journal's full output. Source: SCImago Journal Rank 2025 edition, from Scopus data (scimagojr.com, CC BY-NC).

Current Opinion in Rheumatology is Q1 in Rheumatology (2025 edition, #12 of 78 journals), with SJR 1.572 (Scimago) and an h-index of 155 (OpenAlex). Listed in Scopus, Web of Science, PubMed.

Is this the right journal for your paper?

The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.

Try the Journal Finder →

Indexing & access

Indexed in
ScopusWeb of SciencePubMed
Access status:
hybrid. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.

Official journal site →

Scope

rheumatoidarthritistherapiesrheumatologysystemiclupuserythematosusspondyloarthritistreatmentssclerosisdiseasespathology

Frequently asked

Is Current Opinion in Rheumatology a predatory journal?

Our screening does not flag Current Opinion in Rheumatology. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.

Is Current Opinion in Rheumatology indexed in Scopus or Web of Science?

Per our venue index, Current Opinion in Rheumatology appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.

What is the impact factor of Current Opinion in Rheumatology?

Papers in Current Opinion in Rheumatology are cited about 3.9 times each within two years of publication, and Scimago places it in Q1, with an h-index of 155. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.

What Scimago quartile is Current Opinion in Rheumatology (Q1, Q2, Q3, or Q4)?

In the Scimago Journal Rank 2025 edition, Current Opinion in Rheumatology is Q1 in Rheumatology (#12 of 78 journals). Quartiles split the journals in a subject category into four equal groups by SJR, so Q1 is the most-cited quarter and Q4 the least; Current Opinion in Rheumatology is cited about 3.9 times per paper over two years, with an h-index of 155.

What is the Web of Science (JCR) quartile of Current Opinion in Rheumatology?

The Web of Science quartile comes from Clarivate's Journal Citation Reports (JCR), a proprietary product we neither license nor compute — so we cannot state a JCR quartile for Current Opinion in Rheumatology. The open equivalent is its Scimago quartile, Q1, derived from Scopus citation data. Because JCR ranks against Web of Science and Scimago against Scopus, the two can differ, so check Clarivate's site directly if you need the JCR quartile specifically.

Is Current Opinion in Rheumatology open access?

Our index records its access status as "hybrid". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.

Ready to submit? Tools for your next paper

How Pre-Check worksHow AI Review works

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Similar venues

Compare it with its peers: Ranked Medicine journals — ranked by Scimago quartile and cites per paper, predatory venues excluded.

Command palette

Jump anywhere, run any action.